Stockscreener 앱 받기
0.29%
시간 외 거래:
Amgen Inc 주식(AMGN)의 최신 뉴스
Strong Results and Pipeline Momentum Power Amgen’s (AMGN) 2025 Rally - Insider Monkey
Amgen stock dips as Lumakras combo trial ends; MariTide data now the next watch - ts2.tech
Can Amgen's MariTide Take on Leaders in the Obesity Space? - The Globe and Mail
Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Argus Adjusts Price Target on Amgen to $360 From $310, Maintains Buy Rating - marketscreener.com
Diversified Trust Co Has $12.05 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
The Truth About Amgen Inc.: Is This Biotech Giant the Next Big Money Gamechanger? - AD HOC NEWS
Amgen Inc.: How a Biotech Veteran Is Rebuilding Its Flagship Pipeline - AD HOC NEWS
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus - ts2.tech
Verastem ends trial of Avmapki Fakzynja combo with Amgen's Lumakras in NSCLC - Seeking Alpha
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc. - MarketBeat
Amgen Inc. Stock (AMGN) Opinions on 2025 Revenue Guidance and Drug Sales - Quiver Quantitative
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
Carnegie Investment Counsel Has $30.27 Million Stake in Amgen Inc. $AMGN - MarketBeat
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Check out Amgen's stock price (AMGN-CA) in real time - CNBC
Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc. - MarketBeat
Avanza Fonder AB Purchases 4,546 Shares of Amgen Inc. $AMGN - MarketBeat
Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)? - simplywall.st
Brookstone Capital Management Acquires 16,042 Shares of Amgen Inc. $AMGN - MarketBeat
Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC - MarketBeat
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know - The Globe and Mail
Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - MarketBeat
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd. - MarketBeat
Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail
Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat
Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat
Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech
Fitch upgrades Amgen to ’BBB+’ on improved financial structure By Investing.com - Investing.com Nigeria
Fitch upgrades Amgen to ’BBB+’ on improved financial structure - Investing.com
Fitch raises Amgen credit rating, outlook stable - breakingthenews.net
Our Workforce - Amgen
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025 - ts2.tech
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors - TipRanks
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease - TipRanks
Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus - Kalkine Media
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease - MSN
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025) - ts2.tech
Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements - simplywall.st
The Best Dividend ETF to Buy: SCHD Pays a High Yield While VIG Focuses on Dividend Growth - The Motley Fool
Sarasin & Partners LLP Buys 47,873 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC - MarketBeat
Signal Advisors Wealth LLC Has $867,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA - MarketBeat
Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts - ts2.tech
Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN - MarketBeat
Bartlett & CO. Wealth Management LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
Has Amgen’s 26% Rally in 2025 Already Priced In Its Obesity and Oncology Ambitions? - Yahoo Finance
Is Amgen Inc. stock a top momentum playWeekly Stock Summary & Daily Stock Trend Watchlist - ulpravda.ru
Amgen to Cut US Drug Prices, Expand Patient Access - marketscreener.com
Amgen takes action with U.S. government to lower medicine costs By Investing.com - ca.investing.com
Amgen says Aimovig & Amjevita to be available at discounted monthly price of $299 under deal with U.S. govt - marketscreener.com
Amgen (AMGN) Moves to Reduce Drug Prices in Collaboration with U - GuruFocus
Amgen Strikes Agreement With US Government to Lower Drug Costs - marketscreener.com
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS - PR Newswire
Amgen Advances Olpasiran Heart Plaque Study, Highlighting a Growing Bet on Lipoprotein(a) - TipRanks
Talbot Financial LLC Purchases 5,839 Shares of Amgen Inc. $AMGN - MarketBeat
1.38%
0.81%
자본화:
|
볼륨(24시간):